Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis

Scandinavian Journal of Immunology

Volumn 68, Issue 3, 2008, Pages 323-327

  Sulik, A ^a   Wojtkowska, M ^a   Oldak, E ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHO VIRUS; ECHOVIRUS TYPE 30 MENINGITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MUMPS; MUMPS MENINGITIS; NEUTROPHIL COUNT; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; STATISTICAL ANALYSIS; VIRUS MENINGITIS;

CHILD; ENTEROVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MENINGITIS, ASEPTIC; MUMPS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 48749099979     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02137.x     Document Type: Article

References (24)

1. Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001 36: 249 57.
2. Sellebjerg F, Sorensen TL. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 2003 61: 347 55.
3. Campbell IL, Pagenstecher A. Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic. Trends Neurosci 1999 22: 285 7.
4. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000 1477: 267 83.
5. Gardner J, Ghorpade A. Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res 2003 74: 801 6.
6. Crocker SJ, Pagenstecher A, Campbell IL. The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 2004 75: 1 11.
7. Zimmerman L, Reef S, Wharton M. Mumps. In: Wharton M, Hughes H, Reilly M, eds. Manual for the Surveillance of Vaccine Preventable Diseases, 3rd edn. Atlanta: CDC, 2002: 7/1 12.
8. Kolb SA, Lahrtz F, Paul R et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol 1998 84: 143 50.
9. Lee KY, Kim EH, Yang WS et al. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 2004 220: 73 8.
10. Lindberg RL, Sorsa T, Tervahartiala T et al. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol 2006 32: 304 17.
11. Matsuura E, Umehara F, Hashiguchi T, Fujimoto N, Okada Y, Osame M. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci 2000 173: 45 52.
12. Ichiyama T, Maeba S, Suenaga N, Saito K, Matsubara T, Furukawa S. Analysis of cytokine levels in cerebrospinal fluid in mumps meningitis: comparison with echovirus type 30 meningitis. Cytokine 2005 30: 243 7.
13. Johnatty RN, Taub DD, Reeder SP et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997 158: 2327 33.
14. Robinson SC, Scott KA, Balkwill FR. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol 2002 32: 404 12.
15. Yushchenko M, Weber F, Mader M et al. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J Neuroimmunol 2000 110: 244 51.
16. Azeh I, Mader M, Smirnov A, Beuche W, Nau R, Weber F. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci Lett 1998 256: 127 30.
17. Shapiro S, Miller A, Lahat N, Sobel E, Lerner A. Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis. J Neurol Sci 2003 206: 43 8.
18. Carrol ED, Beadsworth MB, Jenkins N et al. Clinical and diagnostic findings of an echovirus meningitis outbreak in the north west of England. Postgrad Med J 2006 82: 60 4.
19. Szabo K, Ablin R, Singh G. Matrix metalloproteinases and the immune response. Clin Appl Immunol Rev 2004 4: 295 319.
20. Chen KM, Lee HH, Chou HL, Liu JY, Tsai BC, Lai SC. Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis. Int J Exp Pathol 2005 86: 81 9.
21. Martinez-Torres FJ, Wagner S, Haas J et al. Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis. Neurosci Lett 2004 368: 274 8.
22. Avolio C, Filippi M, Tortorella C et al. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler 2005 11: 441 6.
23. Khuth ST, Akaoka H, Pagenstecher A et al. Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol 2001 75: 8268 82.
24. Kettlun AM, Cartier L, Garcia L et al. TIMPs and MMPs expression in CSF from patients with TSP/HAM. Life Sci 2003 72: 2863 76.